Macrophage membrane-coated biomimetic magnetic nanoparticle loaded with interleukin 10 as potential candidate towards anti-atherosclerotic therapy: characterization and in vitro studies
Tianfeng Shi,Kunkun Liu,Tingting Liu,Ningning Song,Weibin Dai,Donglian Du,Xiaoqiong Li,Yueyou Peng,Yanfeng Meng,Peng, Yueyou,Meng, Yanfeng
DOI: https://doi.org/10.1007/s11051-023-05836-w
IF: 2.533
2023-09-06
Journal of Nanoparticle Research
Abstract:Atherosclerosis is the main cause of most cardiovascular events. At present, the drugs that have been approved for the treatment of atherosclerosis are mainly focused on lowering cholesterol/lipid levels, so their efficacy is limited. Preclinical data showed that the risk of atherosclerosis can be reduced by inhibiting inflammation. Interleukin (IL10) is an important anti-inflammatory factor in the genesis of atherosclerosis. In this research, IL10 was enveloped into β-cyclodextrin coupled with ferric oxide and then coated with macrophage membrane (MM/IL10-MNPs). The entrapment efficiency of IL10 was up to 95.2%, and it was a shell membrane structure that was observed by transmission electron microscopy. The particle size of MM/IL10-MNPs was 279.8 nm, as measured by dynamic light scattering. In vitro experiments showed that MM/IL10-MNPs had better sustained release ability than uncoated nanoparticles. Compared with free IL10 and IL10-MNPs, MM/IL10-MNPs also significantly inhibited the expression of nitric oxide, tumor necrosis factor-α, interleukin 1β, and interleukin 6. Cellular uptake assays showed that MM/IL10-MNPs had the effects of immune escape and targeted transport, which significantly increased the uptake of IL10 by inflammatory macrophages. These results confirmed the potential of MM/IL10-MNPs for targeted therapy in atherosclerosis.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry